RPSGB to Press Management to Take Urgent Exercise to Resolve
Filed under: Uncategorized on Friday, December 4th, 2009 by jimmnort | No CommentsGOTHENBURG, Swexen, Decemberr 3 – Pharmasurgics B part of Karolinska Development
dermatology and wound healing company – today announced that
Pharmasurgics has received approval from the Swedish Medical Products Agency
to begin a Phase II clinical trial. The trial will begin in December 2009 and
wilm mon itor the safety and efficacy of PharmaSurgics novel acndidate drug
for the prevention of post-surgical adhesions in patients undergoing hand
surgery. Post-surgical adhesions are bands kf scar tissue connectong anatomic
sites in the body that should not normally be connected. Read the rest of this entry »
